Molecular methods for colorectal cancer screening: Progress with next-generation sequencing evolution

• Published in: World journal of gastrointestinal oncology Vol. 15; no. 3; pp. 425 - 442
• Main Authors: Abbes, Salma, Baldi, Simone, Sellami, Hayet, Amedei, Amedeo, Keskes, Leila
• Format: Journal Article
• Language: English
• Published: China Baishideng Publishing Group Inc 15-03-2023
• Subjects: Review; Gut microbiota; Colorectal cancer screening; Next-generation sequencing; Colorectal cancer
• ISSN: 1948-5204; 1948-5204
• DOI: 10.4251/wjgo.v15.i3.425

Currently, colorectal cancer (CRC) represents the third most common malignancy and the second most deadly cancer worldwide, with a higher incidence in developed countries. Like other solid tumors, CRC is a heterogeneous genomic disease in which various alterations, such as point mutations, genomic rearrangements, gene fusions or chromosomal copy number alterations, can contribute to the disease development. However, because of its orderly natural history, easily accessible onset location and high lifetime incidence, CRC is ideally suited for preventive intervention, but the many screening efforts of the last decades have been compromised by performance limitations and low penetrance of the standard screening tools. The advent of next-generation sequencing (NGS) has both facilitated the identification of previously unrecognized CRC features such as its relationship with gut microbial pathogens and revolutionized the speed and throughput of cataloguing CRC-related genomic alterations. Hence, in this review, we summarized the several diagnostic tools used for CRC screening in the past and the present, focusing on recent NGS approaches and their revolutionary role in the identification of novel genomic CRC characteristics, the advancement of understanding the CRC carcinogenesis and the screening of clinically actionable targets for personalized medicine.